Related Experiment Videos
VATS port site recurrence: a technique dependent problem.
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Annals of Surgical Oncology
|March 22, 2001
Summary
Video-assisted thoracic surgery (VATS) wedge resection for malignancy is safe, with a low port site recurrence rate of 0.26%. Adhering to oncologic principles minimizes this risk in cancer patients.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Video-assisted thoracic surgery (VATS) is a common approach for thoracic malignancies.
- Port site tumor recurrence is a known complication of VATS, but its incidence is not well-established.
- Determining the incidence of port site recurrence after VATS wedge resection is crucial for patient safety and treatment planning.
Purpose of the Study:
- To determine the incidence of port site tumor recurrence after VATS wedge resection for malignancy.
- To evaluate the safety and efficacy of VATS wedge resection in cancer patients.
- To identify factors influencing port site recurrence.
Main Methods:
- Analysis of a prospective VATS database from 1992 to 1996.
- Inclusion of patients undergoing VATS wedge resection for malignancy (excluding pleural biopsy only).
- Parameters analyzed: demographics, surgical technique, and port site recurrences identified via physical exam or CT scan.
Main Results:
- 410 patients underwent VATS wedge resection for malignancy (median age 61).
- Operative mortality was 0.25%.
- With a median follow-up of 25 months for 374 patients, only one port site recurrence (0.26%) was identified.
Conclusions:
- VATS wedge resection is a safe procedure for cancer patients.
- Adherence to oncologic principles, including wide lesion removal and meticulous specimen extraction, results in a low incidence of port site tumor recurrence.
- Conversion to thoracotomy for definitive or extensive cancer operations is a key principle to maintain safety and oncologic outcomes.